title: [Predictive value of cerebellar growth and general movements assessments for neurodevelopment of very preterm infants at 18-24 months' corrected age].
abstract: BACKGROUND
  Fidgety movements assessments is very sensitive predicting long-term outcome or cerebral palsy of preterm, disrupted cerebellar growth has been reported in these patients.
  
  
  OBJECTIVE
  To compare the predictive value of cerebellar ultrasound growth and fidgety movements assessments, for neurodevelopment outcome of very preterm at 18-24 month's corrected age (CA).
  
  
  METHODS
  Prospective study of 88 infants cohort (<= 32 weeks' gestation), transverse cerebellar diameter was obtained by ultrasound via mastoid fontanel, in a weekly basis, until 40 weeks CA. Fidgety movements were assessed at 3 months CA. Neurodevelopment outcome at 18-24 month's CA was evaluated in 68 using Schedule of Growing Skills II Scale (SGS-II) and Amiel-Tison Neurologic Assessment (ATNA).
  
  
  RESULTS
  At term age, cerebellar growth was under 3rd percentile in 11 (10.3%). Fidgety movements were normal in 42 (61.8%) and abnormal or absent in 7 (10.3%). At 18-24 months CA, 54 (79.4%) were normal by the SGS-II and in 6 (8.8%) ATNA classified as cerebral palsy. Cerebellar diameter under 3rd percentile at term was associated with abnormal motor outcome and normal fidgety movements correlated with normal neurodevelopment.
  
  
  CONCLUSIONS
  Ultrasound cerebellar measurements and functional examinations (fidgety movements) have important complementary roles in predicting neurodevelopment of very preterm.
authors.affiliation: Hospital Fernando da Fonseca, Lisboa, Portugal.
authors.forename: M
authors.initials: M
authors.lastname: Cunha
authors.affiliation: Hospital Fernando da Fonseca, Lisboa, Portugal.
authors.forename: F
authors.initials: F
authors.lastname: Correa
authors.affiliation: Hospital Fernando da Fonseca, Lisboa, Portugal.
authors.forename: A
authors.initials: A
authors.lastname: Cadete
authors.affiliation: Hospital Fernando da Fonseca, Lisboa, Portugal.
authors.forename: A
authors.initials: A
authors.lastname: Oliveira
authors.affiliation: Hospital Fernando da Fonseca, Lisboa, Portugal.
authors.forename: H
authors.initials: H
authors.lastname: Figueiredo
authors.affiliation: Hospital Fernando da Fonseca, Lisboa, Portugal.
authors.forename: P
authors.initials: P
authors.lastname: Valerio
authors.affiliation: Hospital Fernando da Fonseca, Lisboa, Portugal.
authors.forename: R
authors.initials: R
authors.lastname: Barroso
authors.affiliation: Hospital Fernando da Fonseca, Lisboa, Portugal.
authors.forename: H
authors.initials: H
authors.lastname: Carreiro
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D016022:Case-Control Studies; D002508:Cephalometry; D002531:Cerebellum / Q000000981:diagnostic imaging* / Q000254:growth & development / Q000503:physiopathology; D002547:Cerebral Palsy / Q000503:physiopathology; D002657:Child Development; D005260:Female; D005865:Gestational Age; D006801:Humans; D007223:Infant; D007234:Infant, Premature; D007235:Infant, Premature, Diseases; D009069:Movement Disorders / Q000209:etiology / Q000503:physiopathology; D009460:Neurologic Examination; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D011446:Prospective Studies; D014463:Ultrasonography / Q000379:methods*
chemical_list: D000305:Adrenal Cortex Hormones